Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

Drug design, development and therapy2015Zhang LF, Zhou ZW, Wang ZH, et al.

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Amyloid beta-PeptidesAnimalsCaffeineCell SurvivalCoffeeDose-Response Relationship, DrugMelatoninMiceMolecular Docking SimulationProtein Aggregation, PathologicalProtein MultimerizationStructure-Activity RelationshipTumor Cells, Culturedtau Proteins

DOI 10.2147/dddt.s71106

PMID 25565776

View source →